Prevention of Pulmonary Vascular and Myocardial Remodeling by the Combined Tyrosine and Serine-/Threonine Kinase Inhibitor, Sorafenib, in Pulmonary Hypertension and Right Heart Failure
European Respiratory Review - United Kingdom
doi 10.1183/09059180.00010805
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2008
Authors
Publisher
European Respiratory Society (ERS)